Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BREAST AND COLORECTAL CANCER, SUSCEPTIBILITY TO
|
7 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
BREAST CANCER, SUSCEPTIBILITY TO
|
24 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
CANCER OF MULTIPLE TYPES, SUSCEPTIBILITY TO
|
1 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
COLORECTAL CANCER, SUSCEPTIBILITY TO
|
8 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
Li-Fraumeni Syndrome 2
|
11 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
PROSTATE CANCER, SUSCEPTIBILITY TO
|
6 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
Carcinoma, Lobular
|
1 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1 | 2005 | 2005 | ||||||
Differentiated Thyroid Gland Carcinoma
|
80 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1 | 2014 | 2014 | ||||||
Liver carcinoma
|
942 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1 | 2013 | 2013 | ||||||
Neoplasm Metastasis
|
327 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.020 | 0.500 | 2 | 2016 | 2019 | |||||
Colorectal Carcinoma
|
1962 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.090 | 0.889 | 9 | 2006 | 2013 | |||||
Breast Carcinoma
|
2793 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.900 | 0.895 | 19 | 2003 | 2017 | |||||
Malignant neoplasm of breast
|
3417 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.800 | 0.929 | 28 | 2001 | 2016 | |||||
Neoplastic Syndromes, Hereditary
|
6387 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 1.000 | 32 | 2001 | 2016 | |||||
Malignant Neoplasms
|
1641 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.090 | 1.000 | 9 | 2006 | 2013 | |||||
Primary malignant neoplasm
|
1374 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.090 | 1.000 | 9 | 2006 | 2013 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.070 | 1.000 | 7 | 2006 | 2013 | |||||
Carcinoma of lung
|
1204 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.730 | 1.000 | 4 | 2008 | 2016 | |||||
Malignant neoplasm of lung
|
1142 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.730 | 1.000 | 4 | 2008 | 2016 | |||||
Familial (FPAH)
|
276 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.030 | 1.000 | 3 | 2006 | 2019 | |||||
Malignant neoplasm of prostate
|
1082 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.030 | 1.000 | 3 | 2004 | 2008 | |||||
Papillary thyroid carcinoma
|
204 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.030 | 1.000 | 3 | 2011 | 2015 | |||||
Primary malignant neoplasm of lung
|
981 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.030 | 1.000 | 3 | 2008 | 2016 | |||||
Prostate carcinoma
|
1168 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.030 | 1.000 | 3 | 2004 | 2008 | |||||
Malignant neoplasm of thyroid
|
103 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.020 | 1.000 | 2 | 2004 | 2015 |